Secondhand smoke: facts and lies.
Mexico ratified the Framework Convention for Tobacco Control in 2004 and is obligated to move forward with implementing its provisions, including Article 8 (Protection from exposure to tobacco smoke). The country has already faced opposition from the tobacco industry. This paper addresses industry tactics against tobacco control, describing the general strategies that have been pursued and the evidence relevant to combating these strategies. The approaches taken by the industry in an effort to discredit the scientific foundation for promoting smokefree environments, the efforts by the industry to propose ventilation of indoor spaces and separation of smokers from nonsmokers as an effective alternative to smokefree places, and finally, the strategy of raising fear of economic losses on the part of the hospitality industry and thereby gaining this sector as an ally in campaigning against smokefree policies are considered. As reviewed in this article: 1) There is scientific consensus on the adverse effects of inhaling SHS; 2) Only smokefree places fully protect nonsmokers from inhaling SHS; and 3) Smokefree policies do not bring economic harm to the hospitality industry.
Department of Epidemiology, The Institute for Global Tobacco Control, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA. jsamet@jhsph.edu
Jonathan M
JM
Samet
D000329:Advertising / Q000941:ethics / Q000331:legislation & jurisprudence; D000395:Air Pollutants, Occupational / Q000009:adverse effects; D016902:Air Pollution, Indoor / Q000009:adverse effects / Q000331:legislation & jurisprudence / Q000517:prevention & control; D002274:Carcinogens, Environmental / Q000009:adverse effects; D032921:Consensus; D008192:Deception; D055317:Evidence-Based Practice; D006331:Heart Diseases / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008800:Mexico; D009369:Neoplasms / Q000209:etiology / Q000517:prevention & control; D011633:Public Facilities / Q000191:economics / Q000331:legislation & jurisprudence; D012140:Respiratory Tract Diseases / Q000209:etiology / Q000517:prevention & control; D019460:Tobacco Industry / Q000941:ethics / Q000379:methods; D014028:Tobacco Smoke Pollution / Q000009:adverse effects / Q000331:legislation & jurisprudence / Q000517:prevention & control / Q000706:statistics & numerical data
D000395:Air Pollutants, Occupational; D002274:Carcinogens, Environmental; D014028:Tobacco Smoke Pollution